ARNA Financial Facts
Interest expense: -1.61MLoss from operations: -9.86M
See Full Income Statement
Total assets: 210.25M
Prepaid expenses and other current assets: 4.77M
See Full Balance Sheet
Arena Pharmaceuticals, Inc. (ARNA) Earnings
|
Expand Research on ARNA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -6.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/11  |
 |
Q410 | -$0.23 | -$0.21 | -$0.02 | $4.01M | $4.81M | N/A |  | | Details |
| 11/9/10 |
|
Q310 | -$0.31 | -$0.23 | -$0.08 | N/A | N/A | N/A | | | Details |
| 11/7/13 |
|
Q313 | -$0.08 | -$0.12 | +$0.04 | $3.6M | $5.3M | N/A | | | Details |
| 11/6/12 |
|
Q312 | -$0.07 | -$0.09 | +$0.02 | $1.49M | $3.51M | N/A | | | Details |
| 11/7/16 |
|
Q316 | -$0.05 | -$0.07 | +$0.02 | $19M | $13.99M | N/A | | | Details |
| 5/8/19 | |
Q119 | $12.10 | $13.89 | -$1.79 | $801.1M | $801.7M | N/A | | | Details |
| 3/14/12 |
|
Q411 | -$0.16 | -$0.15 | -$0.01 | $2.08M | $3.49M | N/A | | | Details |
| 8/1/13 |
Q213 | $0.18 | $0.15 | +$0.03 | $68.9M | $57.3M | N/A | | | Details |
